Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity

This publication has 11 references indexed in Scilit:

• PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)
  The Lancet, 1988
• Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
  Proceedings of the National Academy of Sciences, 1987
• Strategies for antiviral therapy in AIDS
  Nature, 1987
• Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
  Proceedings of the National Academy of Sciences, 1986
• Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells
  Analytical Biochemistry, 1985
• Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5'-nucleotidase in human erythrocytes.
  Proceedings of the National Academy of Sciences, 1984
• CIRCULATING CARRIER ERYTHROCYTES - SLOW-RELEASE VEHICLE FOR AN ANTI-LEUKEMIC DRUG, CYTOSINE-ARABINOSIDE
  1982
• A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts
  Analytical Biochemistry, 1979
• 2-Cyanoethyl Phosphate and its Use in the Synthesis of Phosphate Esters¹
  Journal of the American Chemical Society, 1961